← back to search

Megan D. Hoban

Forma Therapeutics (United States) · US
Area of research
Molecular Biology · Genetics
Research interest
Research interests include CRISPR and Genetic Engineering, Virus-based gene therapy research, CAR-T cell therapy research, and RNA Interference and Gene Delivery.
h-index
11
citations
1,670
works
34
NIH funding
primary concept
email

Recent publications

Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
Molecular Therapy 2019cited by 124position: middledoi
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
Cell Reports 2018cited by 140position: middledoi
Analyzing CRISPR genome-editing experiments with CRISPResso
Nature Biotechnology 2016cited by 495position: middledoi
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Molecular Therapy 2016cited by 215position: firstdoi
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease
Blood 2016cited by 180position: firstdoi
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Blood 2015cited by 320position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Donald B. Kohn · University of California, Berkeley5 papers (2015–2019)Zulema Romero · University of California, Los Angeles4 papers (2015–2019)Roger P. Hollis · University of California, Los Angeles4 papers (2015–2019)Joseph Long · Flatiron Health (United States)3 papers (2016–2019)Aaron Cooper · Memorial Sloan Kettering Cancer Center3 papers (2015–2018)Georgia R. Lill · Los Angeles Medical Center3 papers (2015–2018)Beatriz Campo-Fernández · University of California, Los Angeles3 papers (2016–2019)Xiaoyan Wang · Qingdao University2 papers (2018–2019)Stuart H. Orkin · Boston Children's Hospital2 papers (2016–2016)Michelle Ho · National Cancer Institute2 papers (2015–2016)Alok V Joglekar · University of Pittsburgh2 papers (2015–2018)Fabrizia Urbinati · Vital Therapies (United States)2 papers (2015–2016)Dianne Lumaquin · Tri-Institutional PhD Program in Chemical Biology2 papers (2015–2016)Sorel Fitz‐Gibbon · University of California, Los Angeles2 papers (2016–2018)Daniel E. Bauer · Harvard University2 papers (2016–2016)Michael L. Kaufman · University of Colorado Cancer Center2 papers (2015–2018)Xiaoyan Wang · Shaanxi University of Science and Technology1 papers (2015–2015)Peiqi Liu · South China Agricultural University1 papers (2015–2015) · 1 papers (2015–2015)Julie M. Sanchez · University of California, Los Angeles1 papers (2019–2019)